What is 10x Genomics, Inc.'s free cash flow margin?

10x Genomics, Inc. (TXG) reported free cash flow margin of 19.1% in Q1 2026.

What is the long-term trend for 10x Genomics, Inc.'s free cash flow margin?

Over 3 years (2020 to 2025), 10x Genomics, Inc.'s free cash flow margin has grown at a -38.1% compound annual growth rate (CAGR), from -85.2% to 20.2%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

10x Genomics, Inc. TXG Free cash flow margin

Free cash flow margin at other companies

TEC

Bio-TechneTECH

22.3%+4.0pp

BrukerBRKR

1.5%-3.6pp

IlluminaILMN

22.2%+2.0pp

Twist Bioscience CorporationTWST

-23.2%+7.0pp

RevvityRVTY

17%-1.9pp

Bio-Rad LaboratoriesBIO

13.8%-0.2pp

Other financials

Income statement

See full

Revenue$150.8M-2.6%

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

See full

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

See full

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

See full

Market cap$4.41B+154%

Enterprise value$4B+199%

P/S6.9×+4.1×

Profitability

See full

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

Returns & leverage

See full

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Calculated from 10x Genomics, Inc.’s reported figures.

free cash flow/total revenue=19.1%

Based on trailing twelve months.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 10x Genomics, Inc.'s free cash flow margin?: 10x Genomics, Inc. (TXG) reported free cash flow margin of 19.1% in Q1 2026.
What is the long-term trend for 10x Genomics, Inc.'s free cash flow margin?: Over 3 years (2020 to 2025), 10x Genomics, Inc.'s free cash flow margin has grown at a -38.1% compound annual growth rate (CAGR), from -85.2% to 20.2%.
What does free cash flow margin mean?: Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.